Biome Australia (ASX:BIO) Total Equity: A$6.06 Mil (As of Dec. 2025)


ASX:BIO Biome Australia Ltd ASX:BIO
35 GF Score
Price A$0.29
GF Value A$0.70
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Biome Australia Total Equity?

Biome Australia ASX:BIO -1.72% 35 Total Equity is A$6.06 Mil as of Dec. 2025. GuruFocus rates ASX:BIO with a GF Score™ of 35/100 and a GF Value™ of A$0.70 (Possible Value Trap). The stock has 5 warning signs investors should review.

Biome Australia's total equity for the quarter that ended in Dec. 2025 was A$6.06 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Biome Australia Total Equity Historical Data

* Premium members only.

The historical data trend for Biome Australia's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biome Australia Total Equity Chart

Biome Australia Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Total Equity
10.17 6.53 3.59 2.90 4.68

Biome Australia Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.15 2.90 4.53 4.68 6.06
ASX:BIO
35GF Score
Biome Australia Ltd ASX:BIO
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biome Australia Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Biome Australia's Total Equity for the fiscal year that ended in Jun. 2025 is calculated as

Total Equity=Total Assets(Q: Jun. 2025 )-Total Liabilities(Q: Jun. 2025 )
=11.968-7.293
=4.68

Biome Australia's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=12.309-6.249
=6.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of A$6.06 Mil mean?
Biome Australia (ASX:BIO) has a Total Equity of A$6.06 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Biome Australia and its competitors.
Is Biome Australia's Total Equity too high?
Biome Australia's current Total Equity is A$6.06 Mil. Overall, Biome Australia has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Biome Australia's Total Equity compare to KHC and GIS?
Biome Australia's Total Equity of A$6.06 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Consumer Packaged Goods company?
A good Total Equity depends on the Consumer Packaged Goods industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Biome Australia and its competitors. Biome Australia's current Total Equity is A$6.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biome Australia stock overvalued right now?
Based on GuruFocus' analysis, Biome Australia (ASX:BIO) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.70, compared to a current price of A$0.29 — trading 59.3% below its estimated fair value. The current Total Equity is A$6.06 Mil. Biome Australia's overall GF Score™ is 35/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Biome Australia (ASX:BIO), the current Total Equity is A$6.06 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biome Australia (ASX:BIO) Overvalued in 2026?

Based on GuruFocus' analysis, Biome Australia stock appears to be undervalued. The current stock price of A$0.29 is trading 59.3% below its estimated GF Value™ of A$0.70. GuruFocus considers Biome Australia to be Possible Value Trap.

Key valuation signals for ASX:BIO:

  • Total Equity: A$6.06 Mil
  • GF Value™: A$0.70 vs. price of A$0.29 (59.3% below fair value)
  • GF Score™: 35/100 with 5 warning signs

No single metric tells the full story. See the ASX:BIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biome Australia Business Description

Address 192-194 Johnston Street, Collingwood, VIC, AUS, 3066
Biome Australia Ltd licences, develops, and markets evidence-based, complementary medicines, including nutraceuticals vitamins and weight management products and live biotherapeutics. The company has one operating segment: researching, developing, manufacturing and distributing evidence-based products linking the gut and human health. Domestically it caters to Australia and In international markets, the Group distributes and markets its Activated Probiotics range in the United Kingdom and New Zealand through independent health practitioners.
35GF Score

Get the complete analysis for ASX:BIO

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.29
Price
A$0.70
GF Value